Tau <scp>PET</scp> Imaging With [<sup>18</sup><scp>F</scp>]<scp>MK</scp>‐6240: Limited Affinity for Primary Tauopathies and High Specificity for Alzheimer's Disease

[<sup>18</sup>F]MK-6240 tau-PET has a special affinity for tauopathies involving 3R/4R paired helical filaments: AD, PART (Aβ- subjects with MTL-restricted tau-PET signal) and some forms of FTD while most primary tauopathies do not exhibit significant cortical signal. Positive neocortical scans are therefore highly specific for AD tauopathy. Based on those and previous results, we propose a diagnostic flowchart for MCI subjects suspected of AD or another tauopathy which may significantly reduce the need for amyloid PET or CSF measurement.

Authors

Institutions

Publication Details

Journal
European Journal of Neurology
Published
2025-02-01
DOI
https://doi.org/10.1111/ene.70068
Citations
5
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
5.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tau PET Imaging With [18F]MK‐6240: Limited Affinity for Primary Tauopathies and High Specificity for Alzheimer's Disease

Lara Huyghe, Renaud Lhommel, Adrian Ivanoiu, Thomas Gérard et al.
5 citations
European Journal of Neurology
Alzheimer's disease research and treatments
5.82
article

Tau PET Imaging With [18F]MK‐6240: Limited Affinity for Primary Tauopathies and High Specificity for Alzheimer's Disease

Lara Huyghe, Renaud Lhommel, Adrian Ivanoiu, Thomas Gérard, Bernard Hanseeuw, Lisa Quenon, Yasmine Salman, Laurence Dricot, Lise Colmant, Vincent Malotaux, Emilien Boyer
article en
5 citations

Abstract

[<sup>18</sup>F]MK-6240 tau-PET has a special affinity for tauopathies involving 3R/4R paired helical filaments: AD, PART (Aβ- subjects with MTL-restricted tau-PET signal) and some forms of FTD while most primary tauopathies do not exhibit significant cortical signal. Positive neocortical scans are therefore highly specific for AD tauopathy. Based on those and previous results, we propose a diagnostic flowchart for MCI subjects suspected of AD or another tauopathy which may significantly reduce the need for amyloid PET or CSF measurement.

European Journal of NeurologyVol. 32(2)
Cliniques Universitaires Saint-Luc (BE), Harvard University (US), Gordon Center for Medical Imaging (US), Massachusetts General Hospital (US), Walloon Excellence in Lifesciences and Biotechnology (BE), UCLouvain (BE)
Fonds De La Recherche Scientifique - FNRS, Walloon excellence in life sciences and biotechnology
Openalex Percentile: Top 4%
Alzheimer's disease research and treatments
5.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Tau <scp>PET</scp> Imaging With [<sup>18</sup><scp>F</scp>]<scp>MK</scp>‐6240: Limited Affinity for Primary Tauopathies and High Specificity for Alzheimer's Disease — Lara Huyghe, Renaud Lhommel, et al. · European Journal of Neurology (2025) | TGRS Research Map | TGRS